Meredith Brown-Tuttle
Meredith Brown-Tuttle has written and coordinated numerous drug and biologic
submissions to US and international regulatory agencies, developed global regulatory
strategies, and conducted worldwide regulatory intelligence.
Meredith Brown-Tuttle, RAC, FRAPS, has 31 years of industry experience from bench to clinic to
approval of both drugs and devices. Meredith has written and coordinated numerous drug and
biologic submissions to US and international regulatory agencies, developed global regulatory
strategies and conducted worldwide regulatory intelligence. She is currently both Vice
President of Regulatory & Quality at Lyric Pharmaceuticals, Inc. and a strategy/intelligence
consultant at Regulatoium. Meredith has written, managed and led over 30 successful domestic
and international IND and NDA submissions. She is a founding instructor at UC Santa Cruz
Regulatory Certificate Program and author of two books: “IND Submissions: A Primer” and
“Regulatory Intelligence 101.” Meredith graduated with a BA in biological psychology
(neuroscience) from San Jose State University.
Learn more about Meredith
